Literature DB >> 18211978

Paraganglioma after maternal transmission of a succinate dehydrogenase gene mutation.

Pascal Pigny1, Audrey Vincent, Catherine Cardot Bauters, Monelle Bertrand, Vincent Thomas de Montpreville, Michel Crepin, Nicole Porchet, Philippe Caron.   

Abstract

CONTEXT: Inactivating mutations of SDHD, which is mapped to 11q23 and encodes the cybS subunit of succinate dehydrogenase, predispose to hereditary paraganglioma (PGL) and/or pheochromocytoma. So far no disease was shown to occur in case of maternal transmission of a SDHD mutation, suggesting the existence of genomic imprinting. A hypothetic model, involving the loss of the maternal copy of a tumor suppressor gene mapped to 11p15 in the tumoral tissue, has been proposed to explain this mode of inheritance.
OBJECTIVE: Our objective was to investigate the possibility of maternal transmission of SDHD-linked PGL.
DESIGN: A three-generation family carrying the SDHD W43X mutation was studied at the clinical, pathological, and genetical levels.
RESULTS: The germline's mutation was probably inherited from the grandfather. In the second generation, three carriers (two females and one male), who had the same at risk 11q13-q23 haplotype, developed multiple cervical PGLs. In the third generation, one boy received the mutation from his mother and developed a glomus tympanicum PGL at 11 yr. He shared only the 11q23 haplotype with the other affected members of the family. Methylation analysis of the differentially methylated region upstream of the maternally expressed H19 gene, mapped to 11p15, showed that the seventh CTCF binding site is hypermethylated in the germline of the affected boy suggesting a gain of imprinting.
CONCLUSION: Our data show that maternal transmission of a SDHD-linked PGL, even if a rare event, can occur. Therefore, we propose that children who inherited a pathogenic mutation from their mother should be considered as at risk of PGL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211978     DOI: 10.1210/jc.2007-1989

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

Review 1.  Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Authors:  Lauren Fishbein; Katherine L Nathanson
Journal:  Cancer Genet       Date:  2012 Jan-Feb

2.  Malignant phenotype and two SDHD mutations in a family with paraganglioma syndrome type 1.

Authors:  Franciele B Leidenz; Luciana Bastos-Rodrigues; Marcelo Oliveira; Marcelo Mamede; Marta Sarquis; Eitan Friedman; Luiz de Marco
Journal:  Genet Res (Camb)       Date:  2015-03-30       Impact factor: 1.588

3.  A systematic review on the genetic analysis of paragangliomas: primarily focused on head and neck paragangliomas.

Authors:  A Guha; Z Musil; A Vicha; T Zelinka; K Pacak; J Astl; M Chovanec
Journal:  Neoplasma       Date:  2019-06-29       Impact factor: 2.575

4.  Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation.

Authors:  Monica L Marvin; Carol R Bradford; James C Sisson; Stephen B Gruber
Journal:  Head Neck       Date:  2009-05       Impact factor: 3.147

5.  Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.

Authors:  Mariola Peczkowska; Zoran Erlic; Michael M Hoffmann; Mariusz Furmanek; Jaroslaw Cwikla; Agata Kubaszek; Aleksander Prejbisz; Zbigniew Szutkowski; Andrzej Kawecki; Krzysztof Chojnowski; Anna Lewczuk; Mieczyslaw Litwin; Witold Szyfter; Martin A Walter; Maren Sullivan; Charis Eng; Andrzej Januszewicz; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

6.  A legacy of tinnitus: multiple head and neck paragangliomas.

Authors:  Tricia M M Tan; Emma C I Hatfield; Rajesh V Thakker; Eamonn R Maher; Karim Meeran; Niamh M Martin; Jeremy J Turner
Journal:  Rare Tumors       Date:  2009-12-28

7.  Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome.

Authors:  Montserrat Ayala-Ramirez; Glenda G Callender; Michael E Kupferman; Thereasa A Rich; Hubert H Chuang; Jonathan Trent; Nancy D Perrier; Mahmoud Goodarzi; Camilo Jimenez
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

8.  The approach to the patient with paraganglioma.

Authors:  Hartmut P H Neumann; Charis Eng
Journal:  J Clin Endocrinol Metab       Date:  2009-08       Impact factor: 5.958

9.  The Dutch founder mutation SDHD.D92Y shows a reduced penetrance for the development of paragangliomas in a large multigenerational family.

Authors:  Erik F Hensen; Jeroen C Jansen; Maaike D Siemers; Jan C Oosterwijk; Annette Hjt Vriends; Eleonora Pm Corssmit; Jean-Pierre Bayley; Andel Gl van der Mey; Cees J Cornelisse; Peter Devilee
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

10.  The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.

Authors:  Jean-Pierre Bayley; Anneliese E M Grimbergen; Patrick A van Bunderen; Michiel van der Wielen; Henricus P Kunst; Jacques W Lenders; Jeroen C Jansen; Robin P F Dullaart; Peter Devilee; Eleonora P Corssmit; Annette H Vriends; Monique Losekoot; Marjan M Weiss
Journal:  BMC Med Genet       Date:  2009-04-15       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.